Sale!

Prothrombin Gene Mutation Analysis Test

770 د.إ

-10%

The Prothrombin Gene Mutation Analysis Test is a specialized genetic test conducted to detect mutations in the prothrombin gene, which is a key factor in the blood clotting process. Mutations in this gene, particularly the G20210A mutation, are associated with an increased risk of developing blood clots, deep vein thrombosis (DVT), and other thrombotic conditions. Identifying the presence of this mutation can help healthcare providers assess a patient’s risk for these conditions and guide decisions regarding preventive measures or treatments.

This test involves a simple blood draw, where the DNA is extracted from the blood cells and analyzed for the specific mutation. It is particularly recommended for individuals with a personal or family history of thrombosis or unexplained blood clotting events.

In the UAE, this test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the Prothrombin Gene Mutation Analysis Test at DNA Labs UAE is 770 AED. Given the implications of the results for an individual’s health management, this test is a valuable tool for those with a predisposition to thrombotic events, allowing for timely and informed healthcare decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PROTHROMBIN GENE MUTATION ANALYSIS Test

Test Name: PROTHROMBIN GENE MUTATION ANALYSIS

Test Components: Price – 770.0 AED

Sample Condition: 3 mL (1.5 mL/min.) whole blood in 1 LavenderTop (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: Sample Mon/Thu by 11 am; Report Wed/Sat

Method: Real Time PCR

Test Type: Thromboembolic disorders

Doctor: Hematologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

About the Prothrombin Gene Mutation Analysis Test

The Prothrombin Gene Mutation Analysis test is a genetic test used to detect a specific mutation in the prothrombin gene. This mutation, known as the prothrombin gene mutation or factor II mutation, is associated with an increased risk of blood clots, particularly in the veins (venous thromboembolism).

The test involves analyzing a blood sample to determine if the prothrombin gene mutation is present. The mutation is a change in the DNA sequence of the prothrombin gene, which leads to an increased production of prothrombin, a protein involved in blood clotting. This increased production of prothrombin can result in the formation of abnormal blood clots.

Who Should Take the Test?

The Prothrombin Gene Mutation Analysis test is typically ordered for individuals with a personal or family history of blood clots, especially if the clots occurred at a young age or without any known risk factors. It may also be ordered for individuals who have experienced recurrent blood clots or those who have had unexplained pregnancy complications, such as recurrent miscarriages or fetal growth restriction.

By identifying the presence of the prothrombin gene mutation, healthcare providers can better assess an individual’s risk of developing blood clots and determine appropriate treatment or preventive measures. Treatment may involve the use of anticoagulant medications to prevent clot formation or lifestyle modifications to reduce the risk of clotting.

It is important to note that the Prothrombin Gene Mutation Analysis test is not a routine screening test and is typically only ordered for individuals with specific risk factors or symptoms. The test results should be interpreted by a healthcare professional in the context of the individual’s medical history and other relevant factors.

Test Name PROTHROMBIN GENE MUTATION ANALYSIS Test
Components
Price 770.0 AED
Sample Condition 3 mL (1.5mLmin.)whole blood in 1 LavenderTop (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Mon / Thuby 11 am;Report Wed/Sat
Method Real Time PCR
Test type Thromboembolic disorders
Doctor Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The Prothrombin Gene Mutation Analysis test is a genetic test used to detect a specific mutation in the prothrombin gene. This mutation, known as the prothrombin gene mutation or factor II mutation, is associated with an increased risk of blood clots, particularly in the veins (venous thromboembolism).

The test involves analyzing a blood sample to determine if the prothrombin gene mutation is present. The mutation is a change in the DNA sequence of the prothrombin gene, which leads to an increased production of prothrombin, a protein involved in blood clotting. This increased production of prothrombin can result in the formation of abnormal blood clots.

The Prothrombin Gene Mutation Analysis test is typically ordered for individuals with a personal or family history of blood clots, especially if the clots occurred at a young age or without any known risk factors. It may also be ordered for individuals who have experienced recurrent blood clots, or for those who have had unexplained pregnancy complications, such as recurrent miscarriages or fetal growth restriction.

By identifying the presence of the prothrombin gene mutation, healthcare providers can better assess an individual’s risk of developing blood clots and determine appropriate treatment or preventive measures. Treatment may involve the use of anticoagulant medications to prevent clot formation or lifestyle modifications to reduce the risk of clotting.

It is important to note that the Prothrombin Gene Mutation Analysis test is not a routine screening test and is typically only ordered for individuals with specific risk factors or symptoms. The test results should be interpreted by a healthcare professional in the context of the individual’s medical history and other relevant factors.